ROKA BIOSCIENCE, INC.

Profile

Company Names

ROKA BIOSCIENCE, INC.

Addresses

20 INDEPENDENCE BOULEVARD, WARREN, NJ 07059

20 INDEPENDENCE BOULEVARD, 4TH FLOOR, WARREN, NJ 07059

10210 GENETIC CENTER DRIVE, SAN DIEGO, CA 92121

Phone Numbers

908-605-4700
212-739-6400

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$91,996,656.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2016-09-21 
$22,500,000.00 
$22,500,000.00 
$0.00 
Equity 
3
2013-11-20 
$16,996,657.00 
$16,996,657.00 
$0.00 
Equity 
2
2013-06-13 
$24,999,999.00 
$24,999,999.00 
$0.00 
Equity 
1
2009-09-10 
$27,500,000.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JIM 
 
BARRET, PHD 
DIRECTOR
ROKA BIOSCIENCE, INC.
JOSH 
 
BILENKER, MD 
DIRECTOR
ROKA BIOSCIENCE, INC.
LARS 
 
BOESGAARD 
EXECUTIVE OFFICER
ROKA BIOSCIENCE, INC.   |  COLUMBIA CARE INC.
FRED 
 
COHEN 
DIRECTOR
PROTEOGENIX INC   |  NODALITY INC   |  NODALITY, INC.   |  QUINTILES TRANSNATIONAL HOLDINGS INC.   |  CARDIODX INC   |  VERACYTE, INC.   |  FIVE PRIME THERAPEUTICS INC   |  XDX, INC.   |  NOVAQUEST HEALTHCARE INVESTMENT FUND, L.P.   |  REVAL HOLDINGS INC   |  NOVAQUEST HEALTHCARE INVESTMENT FUND III, L.P.   |  BNA CHICAGO LLC   |  NOVAQUEST PHARMA OPPORTUNITIES FUND III, L.P.   |  ROKA BIOSCIENCE, INC.   |  RAPID MICRO BIOSYSTEMS, INC.   |  AUXOGYN, INC.   |  CAREDX, INC.   |  PROGYNY, INC.   |  CELL DESIGN LABS, INC.   |  CHICKEN SOUP FOR THE SOUL ENTERTAINMENT, INC.   |  VIDA VENTURES, LLC   |  VVAG SPECIAL FUND LLC   |  ASKLEPIOS BIOPHARMACEUTICAL, INC.   |  VV ATREUS SPECIAL FUND LLC   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  ASCEND GENE + CELL THERAPIES LTD.   |  FIREFLY NEUROSCIENCE, INC.   |  KYVERNA THERAPEUTICS, INC.   |  ASCEND ADVANCED THERAPIES GROUP, INC.   |  OLLIN BIOSCIENCES, INC.
MICHAEL 
P. 
DOYLE 
DIRECTOR
ROKA BIOSCIENCE, INC.   |  TARTAN HOLDINGS, LLC\NEW YORK
DAVID 
 
MCGIRR 
DIRECTOR
ROKA BIOSCIENCE, INC.   |  ARSANIS, INC.   |  X4 PHARMACEUTICALS, INC
JONATHAN 
 
SILVERSTEIN 
DIRECTOR
CERAPEDICS INC   |  ENOBIA PHARMA CORP   |  DFINE INC   |  RELYPSA INC   |  ROKA BIOSCIENCE, INC.   |  ASCENDIS PHARMA A/S   |  AUDENTES THERAPEUTICS, INC.   |  ADICET BIO, INC.   |  RHYTHM PHARMACEUTICALS, INC.   |  SCPHARMACEUTICALS INC.   |  AVEDRO INC   |  NEUROPACE INC   |  SPRINGBOX LABS, INC.   |  ARCUTIS BIOTHERAPEUTICS, INC.   |  SURMOUNT BIO, INC.   |  VANQUA BIO, INC.
STEVEN 
 
SOBIESKI 
EXECUTIVE OFFICER
ROKA BIOSCIENCE, INC.
STEVEN 
T. 
SOBIESKI 
EXECUTIVE OFFICER
ROKA BIOSCIENCE, INC.
PAUL 
 
THOMAS 
DIRECTOR, EXECUTIVE OFFICER
ROKA BIOSCIENCE, INC.   |  PINGORA MSR JV I-A, LP   |  PINGORA MSR JV I-B, LP   |  PINGORA MSR JV FEEDER I-B, LP   |  TRIGGER GAP INVESTMENTS LLC
PAUL 
G. 
THOMAS 
EXECUTIVE OFFICER, DIRECTOR
ROKA BIOSCIENCE, INC.
NICHOLAS 
 
VALERIANI 
DIRECTOR
ROKA BIOSCIENCE, INC.   |  SVELTE MEDICAL SYSTEMS INC
MICHAEL 
J. 
WATTS 
DIRECTOR
ROKA BIOSCIENCE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-09-30
D
Link
BIOTECHNOLOGY 
LABORATORY ANALYTICAL INSTRUMENTS [3826] 
DECLINE TO DISCLOSE 
Equity 
2016-09-21 
2013-12-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-11-20 
2013-06-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-13 
2011-12-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-10 
2011-05-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-10 
2009-09-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
ROTH CAPITAL PARTNERS, LLC
15407